155 related articles for article (PubMed ID: 35468924)
1. TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line.
Morale MG; Tamura RE; Cintra R; Araújo NM; Villa LL
Sci Rep; 2022 Apr; 12(1):6714. PubMed ID: 35468924
[TBL] [Abstract][Full Text] [Related]
2. HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis.
Morale MG; da Silva Abjaude W; Silva AM; Villa LL; Boccardo E
Sci Rep; 2018 Feb; 8(1):3476. PubMed ID: 29472602
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
4. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the Toll-Like Receptor/Nitric Oxide Signaling Pathway in the Pathogenesis of Cervical Cancer Caused by High-Risk Human Papillomavirus Infection.
Li J; Rao H; Jin C; Liu J
Biomed Res Int; 2017; 2017():7830262. PubMed ID: 28626766
[TBL] [Abstract][Full Text] [Related]
6. Cellular landscaping of cisplatin resistance in cervical cancer.
Bhattacharjee R; Dey T; Kumar L; Kar S; Sarkar R; Ghorai M; Malik S; Jha NK; Vellingiri B; Kesari KK; Pérez de la Lastra JM; Dey A
Biomed Pharmacother; 2022 Sep; 153():113345. PubMed ID: 35810692
[TBL] [Abstract][Full Text] [Related]
7. Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells.
Padilla LA; Leung BS; Carson LF
Gynecol Oncol; 2002 Apr; 85(1):59-66. PubMed ID: 11925121
[TBL] [Abstract][Full Text] [Related]
8. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
[TBL] [Abstract][Full Text] [Related]
9. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
10. Expression of integrins and Toll-like receptors in cervical cancer: effect of infectious agents.
Werner J; Decarlo CA; Escott N; Zehbe I; Ulanova M
Innate Immun; 2012 Feb; 18(1):55-69. PubMed ID: 21239458
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV-positive cancer cells in a JNK-dependent manner.
Frensemeier K; Holzer A; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2022 Dec; 151(12):2215-2228. PubMed ID: 36094276
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
13. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer cell lines are sensitive to sub-erythemal UV exposure.
Gu W; Sun S; Kahn A; Dacus D; Wendel SO; McMillan N; Wallace NA
Gene; 2019 Mar; 688():44-53. PubMed ID: 30517878
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus-related cervical cancer cells through the Toll-like receptor 4/nuclear factor-κB pathway.
Jiang N; Xie F; Guo Q; Li MQ; Xiao J; Sui L
Tumour Biol; 2017 Jun; 39(6):1010428317710586. PubMed ID: 28653898
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.
Koivusalo R; Krausz E; Ruotsalainen P; Helenius H; Hietanen S
Cancer Res; 2002 Dec; 62(24):7364-71. PubMed ID: 12499281
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor-4 is a target for suppression of proliferation and chemoresistance in HepG2 hepatoblastoma cells.
Hsiao CC; Chen PH; Cheng CI; Tsai MS; Chang CY; Lu SC; Hsieh MC; Lin YC; Lee PH; Kao YH
Cancer Lett; 2015 Nov; 368(1):144-152. PubMed ID: 26276725
[TBL] [Abstract][Full Text] [Related]
19. Grass carp SARM1 and its two splice variants negatively regulate IFN-I response and promote cell death upon GCRV infection at different subcellular locations.
Yan N; Su J; Yang C; Rao Y; Feng X; Wan Q; Lei C
Dev Comp Immunol; 2015 Jan; 48(1):102-15. PubMed ID: 25280626
[TBL] [Abstract][Full Text] [Related]
20. Glucose-Related Protein 78 Expression and Its Effects on Cisplatin-Resistance in Cervical Cancer.
Luo C; Fan W; Jiang Y; Zhou S; Cheng W
Med Sci Monit; 2018 Apr; 24():2197-2209. PubMed ID: 29650944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
